13 Ekim 2020 Salı

Eli Lilly’s Antibody Trial Is Paused Over Potential Safety Concern


By BY KATHERINE J. WU AND KATIE THOMAS from NYT Health The drugmaker’s experimental antibody treatment is similar to the one President Trump received from Regeneron. https://ift.tt/31lgGsv

Hiç yorum yok:

Yorum Gönder

Routine Childhood Vaccinations in the U.S. Slipped During the Pandemic

By BY BENJAMIN MUELLER AND JAN HOFFMAN from NYT Health Nationwide, the number of kindergartners with the required shots fell below the targ...